Access Considerations for People Aging with HIV: IRA Negotiations and BIKTARVY®
August 28, 2026The Centers for Medicare & Medicaid Services (CMS) recently selected 15 Medicare-covered drugs for the third cycle of Medicare drug price negotiation, known as IPAY 2028, under the Inflation Reduction Act (IRA).
BIKTARVY (bictegravir, emtricitabine, and tenofovir alafenamide), a widely used single-tablet HIV treatment regimen, is one of the selected drugs.
This fact sheet provides information and considerations on these negotiations.
A Multidisciplinary Healthy Aging Program in Comprehensive HIV Care: Multidomain Screening, Clinical Interventions, and Cardiometabolic Risk Management
May 19, 2026New research on HIV and Aging published in the journal Viruses.
Joint Statement and Public Comments on the Proposed Changes to Connecticut’s Medicaid Protected Drug Classes
April 29, 2026ADAP Advocacy and HealthHIV issued the following joint statement in response to the proposed changes to services for People Living with HIV/AIDS (PLWHA) under Medicaid as set forth in the Connecticut Governor’s Health and Human Services budget recommendations.
CMS Town Hall Meeting on Biktarvy Price Negotiations: Comments by Kevin Herwig
April 23, 2026Comments provided by Kevin Herwig, HIV+Hepatitis Policy Institute, during the Centers for Medicare and Medicaid Services Town Hall Meeting on Biktarvy Price Negotiations, April 22, 2026.
MAPRx Recent Medicare Part D Changes, September 2025
October 20, 2025This infographic from MAPRx describes Medicare Part D changes that may help with out of pocket costs.
ICC COVID Immunization Dashboard
October 14, 2025To help navigate the current landscape in each state, the Immunocompromised Collaborative immunization dashboard from the Immune Deficiency Foundation tracks who is eligible for the 2025-2026 COVID-19 vaccine, as well as who can get it from a pharmacy without a prescription and whether state-regulated health insurance plans have to cover the cost.
MAPRx 2026 Open Enrollment Guide
The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2025 – December 7, 2025 for coverage beginning January 1, 2026. Certain people with Medicare can also change plans at other times. Every year plans make changes to benefits and costs. With these different changes, your current plan may or may not be the best plan for you in 2026.
This guide can help find answers to some important questions that can help you during the Annual Open Enrollment.
MAPRx MPPP Patient Guide for 2026
If your prescription drug costs are high, you may benefit from participating in the Medicare Prescription Payment Plan, also known as MPPP. This guide from Medicare Access for Patients Rx describes the Medicare Prescription Payment Plan and helps patients decide if it is right for them.
HIV Prevention Resources for Black Women to Thrive
September 23, 2025As a direct response to insights gathered from an Empower Initiative survey, HealthHIV developed a comprehensive resource guide designed to bridge the gaps in healthcare access for Black women. This guide serves as a vital tool, equipping individuals with the knowledge and support needed to navigate medical systems with confidence.
Fighting for Justice: The Hidden Toll of HIV Laws on Black Women
August 19, 2025This episode unpacks the harsh reality of HIV criminalization and how outdated laws disproportionately harm Black women. These laws—rooted in stigma, not science—undermine public health efforts by discouraging testing, deterring disclosure, and increasing fear around diagnosis. From unjust prosecutions to emotional trauma, we explore how these policies fuel misinformation and widen health disparities. We also highlight the ongoing fight for justice, education, and legal reform—essential steps in creating a supportive environment where HIV prevention, care, and treatment can truly thrive.
NIAID HIV Language Guide
January 24, 2025This guide includes language suggestions for communicating about HIV and related topics.
Patients With HIV May Have High Prevalence of Long COVID
January 15, 2025The prevalence of long COVID was high in patients living with HIV, according to a review published in eClinicalMedicine.
